Evidence map›Paper›PMID 28237627›Full record

ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2017

Utilization of preoperative endoscopic ultrasound for pancreatic adenocarcinoma.

Ryan K Schmocker, David J Vanness, Caprice C Greenberg, Jeff A Havlena, Noelle K LoConte, Jennifer M Weiss, Heather B Neuman, Glen Leverson, Maureen A Smith, Emily R Winslow

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Pancreatic cancer in 2021: What you need to know to win.World journal of gastroenterology · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryan K SchmockerDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA.
David J VannessDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, USA.
Caprice C GreenbergDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA; Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, USA.
Jeff A HavlenaDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA.
Noelle K LoConteDepartment of Medicine, Division of Oncology, University of Wisconsin School of Medicine and Public Health, USA.
Jennifer M WeissDepartment of Medicine, Division of Gastroenterology & Hepatology, University of Wisconsin School of Medicine and Public Health, USA.
Heather B NeumanDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA.
Glen LeversonDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA.
Maureen A SmithDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA; Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, USA.
Emily R WinslowDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, USA. Electronic address: winslow@surgery.wisc.edu.

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
UW Surgical Oncology Research Training Program (UW-SORT)T32CA090217 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Muhammed Murtaza, Heather B Neuman · 2001 to 2026
$8.3M
NCATS NIH HHS UL1 TR000427NCCDPHP CDC HHS U58 DP003862NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000140CNCI NIH HHS T32 CA090217
6 · The paper itself

Abstract

backgroundEndoscopic ultrasound (EUS) is used for pancreatic adenocarcinoma staging and obtaining a tissue diagnosis. The objective was to determine patterns of preoperative EUS and the impact on downstream treatment.

methodsThe Surveillance, Epidemiology, and End Results (SEER) Medicare-linked database was used to identify patients with pancreatic adenocarcinoma. The staging period was the first staging procedure within 6 months of surgery until surgery. Logistic regression was used to determine factors associated with preoperative EUS. The main outcome was EUS in the staging period, with secondary outcomes including number of staging tests and time to surgery.

results2782 patients were included, 56% were treated at an academic hospital (n = 1563). 1204 patients underwent EUS (43.3%). The factors most associated with receipt of EUS were: earlier year of diagnosis, SEER area, and a NCI or academic hospital (all p < 0.0001). EUS was associated with a longer time to surgery (17.8 days; p < 0.0001), and a higher number of staging tests (40 tests/100 patients; p < 0.0001).

conclusionsFactors most associated with receipt of EUS are geographic, temporal, and institutional, rather than clinical/disease factors. EUS is associated with a longer time to surgery and more preoperative testing, and additional study is needed to determine if EUS is overused.

Indexed as

AdenocarcinomaAgedAged, 80 and overEndosonographyFemaleHumansLinear ModelsLogistic ModelsMaleMultivariate AnalysisNeoplasm StagingOdds RatioPancreatectomyPancreatic NeoplasmsPancreaticoduodenectomyPractice Patterns, Physicians'

Identifiers

PMID28237627
PMCPMC5695546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.